News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Hagen Kennecke: Possible breakthrough in cancer cachexia with Ponsegromab
Photo of Hagen Kennecke taken from ohsu.edu
Sep 18, 2024, 12:58

Hagen Kennecke: Possible breakthrough in cancer cachexia with Ponsegromab

Hagen Kennecke, Section chief and Chief Health Officer of the OHSU Knight-Legacy Health Cancer Collaborative, shared on X:

 

“Possible breakthrough in cancer cachexia with Ponsegromab, anti-GDF 15. Significant weight gain, especially in patients with colorectal cancer.”

Ponsegromab for the Treatment of Cancer Cachexia | NEJM

 

Authors: John D. Groarke, Jeffrey Crawford, Susie M. Collins, Shannon Lubaczewski, Eric J. Roeland, Tateaki Naito, Andrew E. Hendifar, Marie Fallon, Koichi Takayama, Timothy Asmis, Richard F. Dunne, M.D., Isik Karahanoglu, Carrie A. Northcott, Magdalena A. Harrington, Michelle Rossulek, Ruolun Qiu, Aditi R. Saxena

Hagen Kennecke

Source: Hagen Kennecke/X

 

 

Aditi R. Saxena Andrew E. Hendifar cancer cancer cachexia Carrie A. Northcott Eric J. Roeland Hagen Kennecke Isik Karahanoglu Jeffrey Crawford John D. Groarke Koichi Takayama M.D. Magdalena A. Harrington Marie Fallon Michelle Rossulek ocnology OncoDaily Ponsegromab Richard F. Dunne Ruolun Qiu Shannon Lubaczewski Susie M. Collins Tateaki Naito Timothy Asmis
Special Coverage
Blog
Sep 26, 2024, 15:08
Mukhtasar Malcolm Alkali: Honored to meet Dan Milner at WCC
Blog
Sep 26, 2024, 15:05
Jill Johnson: Mays Cancer Center is seeking adults receiving treatment for blood cancer to enroll in a remote study
Insight
Sep 26, 2024, 15:04
Stephanie Graff: Ever wondered what 'clinically meaningful' really means
Blog
Sep 26, 2024, 14:52
Carmen Uscatu: Cancer isn’t fair but care should be
Blog
Sep 26, 2024, 14:52
OncoInfluencers to Follow on Social Media: Dr. Bhawna Sirohi
Insight
Sep 26, 2024, 14:37
CCTG NE2 STOPNET Neuroendocrine Study Officially Opens in Canada
Blog
Sep 26, 2024, 14:34
Yakup Ergun: Survival and recurrence rates following SBRT or surgery in operable Stage I NSCLC
Blog
Sep 26, 2024, 14:27
Mehdi Hamadani: Efficacy of axatilimab in chronic graft-versus-host disease
Blog
Sep 26, 2024, 14:24
Ruben A. Mesa: Honored to participate in Career Development session at ⁦AACR Health Equity
Blog
Sep 26, 2024, 14:22
Luis Castelo-Branco: Belzutifan vs everolimus for advanced kidney cancer
Blog
Sep 26, 2024, 14:21
Zed Zha: Doctors’ visits do not equal 'health'
Blog
Sep 26, 2024, 14:19
Paolo Tarantino: ADC stability does not equal ADC tolerability